1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Withdrawal: new trials by email Literature Review of Withdrawal trials Research Report on Withdrawal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Diuretics Withdrawal in Chronic Heart Failure With Reduced Ejection Fraction Diuretics withdrawal, Diuretics maintenance - Heart Failure, Electric Impedance | Phase 2 | Completed | Maimónides Biomedical Research Institute of Córdoba | 98 | 2022-12-19 | 2024-11-04 |
| Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study BZDs + opiate exposure treated with BPN, Opiates exposure treated with BPN - Drug; Withdrawal Symptoms, Neonatal, Withdrawal | Phase 1 / Phase 2 | Unknown | Gauda, Estelle B., M.D. | 40 | 2014-10-01 | 2016-05-06 |
Dyspnea (1) · Edema (1) · Heart Failure (1) · Substance Withdrawal Syndrome (1)
Cardiovascular Diseases (1) · Chemically-Induced Disorders (1) · Heart Diseases (1) · Mental Disorders (1) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1) · Substance-Related Disorders (1)
Buprenorphine (1) · Buprenorphine, Naloxone Drug Combination (1)
Gauda, Estelle B., M.D. (1) · Maimónides Biomedical Research Institute of Córdoba (1)
Spain (1) · United States (1)
Alberto Torres Zamudio, MD (1) · Estelle B Gauda, MD (1)
PMID 21791539, PMID 25176015, PMID 28390780, PMID 30741494, PMID 31424503, PMID 32171764, PMID 32673497, PMID 33736819, PMID 34447992